NLS Pharmaceutics Ltd [NLSP] fell -65.74% so far this year. What now?

NLS Pharmaceutics Ltd [NASDAQ: NLSP] jumped around 0.02 points on Wednesday, while shares priced at $0.20 at the close of the session, up 15.16%.

Compared to the average trading volume of 9.84M shares, NLSP reached a trading volume of 6405742 in the most recent trading day, which is why market watchdogs consider the stock to be active.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

What do top market gurus say about NLS Pharmaceutics Ltd [NLSP]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NLSP shares is $4.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NLSP stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

How has NLSP stock performed recently?

NLS Pharmaceutics Ltd [NLSP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.05. With this latest performance, NLSP shares gained by 58.26% in over the last four-week period, additionally sinking by -59.58% over the last 6 months – not to mention a drop of -77.97% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NLSP stock in for the last two-week period is set at 55.26, with the RSI for the last a single of trading hit 55.96, and the three-weeks RSI is set at 54.22 for NLS Pharmaceutics Ltd [NLSP]. The present Moving Average for the last 50 days of trading for this stock 0.1606, while it was recorded at 0.1896 for the last single week of trading, and 0.3818 for the last 200 days.

NLS Pharmaceutics Ltd [NLSP]: Deeper insight into the fundamentals

NLS Pharmaceutics Ltd’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.23 and a Current Ratio set at 0.23.

Insider trade positions for NLS Pharmaceutics Ltd [NLSP]

The top three institutional holders of NLSP stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in NLSP stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in NLSP stock with ownership which is approximately 5.1238%.